<unk> , sold under the brand name Elelyso among others, is a biopharmaceutical medication developed by Protalix and Pfizer. The drug, a recombinant glucocerebrosidase used to treat Gaucher's disease, is the first plant-made pharmaceutical to win approval by the U.S. Food and Drug Administration (FDA). Each vial has 200 units of<unk> .
Taliglucerase alfa
Velaglucerase alfa
Imiglucerase
Alglucosidase alfa
Avalglucosidase alfa
Dasiglucagon
Vestronidase alfa
Liranaftate